AV
Aberdare Ventures
Venture CapitalActiveAberdare Ventures offers the healthcare industry with seed, early, and later stage venture, private equity, and grants investments.
70
Investments
6
Exits
$500M
AUM
8.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Aberdare Ventures.
Investment Thesis & Strategy
Aberdare Ventures invests in seed to later-stage fintech companies, providing venture capital, private equity, and grants to support growth within the healthcare industry.
Investment Activity
Deals per year over the last 8 years
1
20142
20150
20161
20172
20181
20190
20203
2021Portfolio Companies
Selected investments from their portfolio of 70 companies
V
Vori Health
Healthcare · Series A, 2021
J
Jasper Therapeutics
Biotech · Series A, 2021
M
Medable
Healthcare · Series B, 2021
A
Alto Pharmacy
Healthcare · Series C+, 2019
C
Carbon Health
Healthcare · Series B, 2018
L
Lyra Health
Healthcare · Series B, 2018
V
Viz.ai
Healthcare · Series A, 2017
O
Omada Health
Healthcare · Series B, 2015
H
Healthify
Healthcare · Series A, 2015
G
Grand Rounds
Healthcare · Series B, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
HealthifyAcquisition2024—
Maven ClinicAcquisition2024—
CareBridgeAcquisition2022—
WelltokAcquisition2021—
Grand RoundsAcquisition2021—
Flatiron HealthAcquisition2018$1.9B
Frequently Asked Questions
Aberdare Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals